Trump and RFK Jr's Unsupported Autism Claims Spark Surge in Leucovorin Prescriptions

Trump and Robert F. Kennedy Jr. caused an immediate surge in leucovorin prescriptions for children with autism after touting the vitamin B derivative as a treatment, despite a lack of scientific evidence. Outpatient prescriptions rose by 71% in the weeks following their announcement, new research shows, as parents sought the medication in hopes of helping their children.

"The average parent who maybe wasn't getting the right information said, 'Well, to be good parents, we need to try this,'" said William Graf, a professor of pediatrics and neurology at Connecticut Children's Medical Center. However, the FDA later approved leucovorin only for folate deficiency, not autism.

The surge in prescriptions highlighted the impact celebrity endorsements can have, even when not supported by scientific consensus. Many neurodevelopmental doctors were shocked by the claims, bracing for a flood of concerned parents seeking the medication. While some parents may have been motivated by a desire to help their children, the lack of evidence behind the claims raised ethical concerns.

The promotion of leucovorin as an autism treatment by high-profile figures like Trump and Kennedy underscores the need for caution when evaluating unproven medical claims, especially when they originate from non-medical experts. The spike in prescriptions demonstrates how quickly misinformation can spread and influence patient behavior, potentially leading to unnecessary or inappropriate treatments.

Despite the FDA's later clarification that leucovorin is approved only for folate deficiency, the initial promotion likely left a lasting impact, highlighting the challenges healthcare providers face in combating the spread of unsupported medical claims. As the public increasingly turns to social media and celebrity influencers for health information, the need for accurate, science-based guidance has never been more crucial.